Suppr超能文献

原发性气管肿瘤:治疗与结果

Primary tracheal tumors: treatment and results.

作者信息

Grillo H C, Mathisen D J

机构信息

General Thoracic Surgical Unit, Massachusetts General Hospital, Boston 02114.

出版信息

Ann Thorac Surg. 1990 Jan;49(1):69-77. doi: 10.1016/0003-4975(90)90358-d.

Abstract

One hundred ninety-eight patients with primary tracheal tumors were evaluated in 26 years. One hundred forty-seven tumors were excised (74%): 132 (66%) by resection and primary reconstruction, seven by laryngotracheal resection or cervicomediastinal exenteration, and eight by staged procedures. Eleven more were explored. Forty-four squamous cell carcinomas were resected, 60 adenoid cystic, and 43 assorted tumors, benign and malignant. Eighty-two patients underwent tracheal resection with primary reconstruction, and 50 had carinal resection and reconstruction. Surgical mortality for resection with primary reconstruction was 5%, with one death after tracheal and six after carinal repair. Six patients had stenosis after tracheal or carinal resection; all underwent reresection successfully. Nearly all patients with squamous or adenoid cystic carcinoma were irradiated postoperatively. Twenty of 41 survivors of resection of squamous cell carcinoma are living free of disease (some for more than 25 years), 39 of 52 with adenoid cystic carcinoma (up to nearly 19 years), and 35 of 42 with other lesions (5 lost to follow-up). Comparison of length of survival of patients with squamous cell carcinoma and adenoid cystic carcinoma who are alive without disease with those who died with carcinoma supports surgical treatment (usually followed by irradiation). Positive lymph nodes or invasive disease at resection margins appear to have an adverse effect on cure of squamous cell carcinoma; such an effect is not demonstrable with adenoid cystic carcinoma.

摘要

在26年里,对198例原发性气管肿瘤患者进行了评估。147例肿瘤被切除(74%):132例(66%)通过切除并一期重建,7例通过喉气管切除或颈纵隔清扫,8例通过分期手术。另有11例接受了探查。44例鳞状细胞癌被切除,60例腺样囊性癌,43例为各种良恶性肿瘤。82例患者接受了气管切除并一期重建,50例进行了隆突切除和重建。一期重建切除的手术死亡率为5%,气管修复后1例死亡,隆突修复后6例死亡。6例患者在气管或隆突切除后出现狭窄;均成功接受了再次切除。几乎所有鳞状或腺样囊性癌患者术后都接受了放疗。41例鳞状细胞癌切除幸存者中有20例无病存活(部分超过25年),52例腺样囊性癌患者中有39例(长达近19年),42例其他病变患者中有35例(5例失访)。将无病存活的鳞状细胞癌和腺样囊性癌患者的生存时间与死于癌症的患者进行比较,支持手术治疗(通常随后进行放疗)。切除边缘的阳性淋巴结或浸润性疾病似乎对鳞状细胞癌的治愈有不利影响;腺样囊性癌未显示出这种影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验